TGFB1 and neoplasm: Central to this “barrier effect” are cancer-associated fibroblasts (CAFs)—mesenchymal cells that, in response to cytokines such as IL-10 and TGF-β secreted by tumor cells, produce abundant extracellular matrix proteins.